Biofarm Bucure

BIO · RO · Healthcare / Drug Manufacturers - Specialty & Generic

1.37RON+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close1.37

Open1.37

Day Range1.37 – 1.37

52-Week Range0.6883 – 1.38

Volume0

Market Cap1.35B

P/E (TTM)19.57

Forward P/E0.00

EPS0.07

Dividend Yield3.07%

Beta0.50

50-Day Avg1.37

200-Day Avg1.32

About

Biofarm S.A. manufactures pharmaceutical products. The company's products include cardiovascular, digestive and metabolic, genito-urinary, ophthalmological, endocrine, nervous system, osteo-muscular, respiratory and ENT, multivitamin, antiallergen, and dermatological products. Biofarm S.A. was founded in 1921 and is based in Bucharest, Romania. As of June 24, 2026, Biofarm S.A. operates as a subsidiary of Polpharma SA Pharmaceutical Works.

Company Details

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Catalin Constantin Vicol
Employees374
Headquarters99, Logofatul Tautu Street, Bucharest, Romania, 031212, Romania
Websitehttps://www.biofarm.ro

Leadership

Mr. Catalin Constantin VicolCEO & Non-Independent Executive Director · b. 1974
Mr. Mihai ZoescuChief Financial Officer · b. 1979
Mr. Mirel FloricaChief Operations Officer
Ms. Matei Monica Claudia DobrisanChief Accountant
Mr. Gheorghe PaceaTechnical Manager
Mr. Valentin Daniel ConstantinLegal & Investor Relations Manager
Ms. Ioana GoranescuMarketing Manager
Ms. Mariana BogdeHuman Resource Manager
Mr. Rachid El LakisDeputy Chief Executive Officer · b. 1996
Ms. Diana Maria VizitiuControlling & Reporting Department Manager

Financials

Income Statement

Currency: RON	2019-09-30	2020-09-30	2021-09-30	2022-09-30	2023-09-30	2024-09-30	2025-09-30
Total Revenue	195.32M	216.42M	239.04M	276.98M	280.29M	286.77M	319.33M
Growth (%)	-	+10.80%	+10.45%	+15.87%	+1.19%	+2.31%	+11.36%
Cost of Revenue	35.47M	37.93M	39.12M	43.59M	47.83M	44.91M	46.44M
Gross Profit	159.85M	178.49M	199.92M	233.39M	232.46M	241.86M	272.89M
Gross Margin	81.84%	82.47%	83.63%	84.26%	82.94%	84.34%	85.46%
Operating Expense	98.88M	114.78M	131.02M	154.40M	155.17M	163.59M	165.96M
Operating Income	60.97M	63.71M	68.90M	78.99M	77.29M	78.27M	106.93M
Operating Margin	31.21%	29.44%	28.82%	28.52%	27.57%	27.29%	33.49%
EBITDA	-	-	-	94.39M	98.23M	101.42M	133.46M
EBITDA Margin	-	-	-	34.08%	35.05%	35.37%	41.79%
Net Income	50.88M	54.26M	60.36M	70.92M	77.01M	74.40M	100.63M
Net Income Margin	26.05%	25.07%	25.25%	25.60%	27.48%	25.94%	31.51%
Interest Expense	10	5	3	89	2	0	0
Interest Expense % of Total Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Balance Sheet

Currency: RON	2019-09-30	2020-09-30	2021-09-30	2022-09-30	2023-09-30	2024-09-30	2025-09-30
Total Assets	346.62M	372.38M	418.78M	466.54M	493.81M	555.48M	636.87M
Total Liabilities	89.39M	80.82M	85.99M	86.48M	59.40M	77.22M	88.52M
Total Equity	257.23M	291.55M	332.79M	380.06M	434.41M	478.26M	548.35M
Cash	91.13M	54.54M	103.87M	82.71M	20.66M	61.84M	115.25M

Cash Flow

Currency: RON	2011-09-30	2012-09-30	2013-09-30	2019-09-30	2020-09-30	2021-09-30	2022-09-30	2023-09-30	2024-09-30	2025-09-30
Operating Cash Flow	-	-	-	72.96M	39.51M	69.18M	29.02M	79.83M	57.59M	80.52M
Capital Expenditure	0	0	0	19.80M	27.49M	21.45M	30.13M	29.84M	23.41M	14.67M
Free Cash Flow	-	-	-	53.16M	12.02M	47.73M	-1.11M	49.99M	34.18M	65.86M
Dividends Paid	-	-	-	9.44M	29.04M	20.69M	22.55M	28.24M	29.19M	29.23M
FCF to OCF	-	-	-	72.87%	30.42%	68.99%	-3.83%	62.62%	59.34%	81.78%
Dividend Paid to FCF	-	-	-	17.75%	241.58%	43.34%	-2027.16%	56.50%	85.42%	44.39%

Earnings

Report Date	May 14, 2014	Aug 14, 2014	Nov 14, 2014	Feb 12, 2015	Apr 22, 2015	May 15, 2017	Aug 11, 2017	Nov 15, 2017	Feb 14, 2018	Apr 20, 2018	Aug 14, 2018	Nov 12, 2018	Feb 14, 2019	May 14, 2019	Aug 13, 2019	Nov 14, 2019	Feb 14, 2020	May 14, 2020	Aug 13, 2020	Nov 12, 2020	Feb 15, 2021	May 14, 2021	Aug 13, 2021	Nov 11, 2021	Feb 14, 2022	May 13, 2022	Aug 12, 2022	Nov 14, 2022	Feb 13, 2023	May 17, 2023
EPS Estimate	0.01	0.01	0.01	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EPS Actual	0.00	0.00	0.00	0.00	0.00	0.01	0.02	0.01	0.01	0.01	0.02	0.01	0.02	0.02	0.03	0.01	0.05	0.02	0.03	0.02	0.06	0.02	0.04	0.02	0.06	0.03	0.02	0.02	0.07	0.00
Surprise	-100.00%	-100.00%	-100.00%	-	-100.00%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	After-hours	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Key Statistics & Ratios

Market Cap1.35B

Enterprise Value1.14B

Trailing P/E19.57

Forward P/E0.00

Price / Sales4.59

Price / Book3.42

EPS0.07

Book Value0.401

Revenue (TTM)294.25M

Gross Profit (TTM)252.39M

EBITDA89.50M

Profit Margin26.59%

Operating Margin-23.94%

Return on Equity17.55%

Return on Assets7.14%

Shares Outstanding985.37M

Shares Float476.14M

Beta0.50

Dividend Yield3.07%

Dividend Rate0.04

Payout Ratio105.19%

Dividends

20262×

0.14Jun 29, 20260.04May 13, 2026

20251×

0.03Aug 18, 2025

20241×

0.03Aug 20, 2024

20231×

0.03Aug 21, 2023

20221×

0.02Aug 22, 2022

20211×

0.02Aug 16, 2021

20202×

0.02Aug 13, 20200.01Mar 5, 2020

20191×

0.01Aug 19, 2019

20181×

0.02Aug 16, 2018

20171×

0.02Aug 17, 2017

20161×

0.02Aug 1, 2016

20151×

0.01Jun 22, 2015

20131×

0.01May 8, 2013

20121×

0.01May 9, 2012

20111×

0.01May 5, 2011